Community Practice

Regardless of its status as an herbal dietary supplement, St. John's Wort is a drug

Alogliptin approved as monotherapy and in two combinations

Remember that Norman Rockwell image of the friendly local pharmacist, running his shop his way? Now blink. Hey! It's still there

Memories of the phenobarb generation

A concise summary of what they didn't teach you in pharmacy school

Policies and procedures for implementation of changes to pharm tech certification will be released later this year

It took the sustained efforts of a few dedicated individuals to persuade the U.S. Postal Service to create a postage stamp honoring pharmacists. To commemorate some of those men and their work, reader John W. Owen, Sr., RPh, speaks up

While not too many bench pharmacists get a lunch hour, creative solutions are still possible. In theory, anyway

Effective communication is the keystone of pharmacy ethics in daily practice

Data from the RE-MEDY trial suggest that Pradaxa is as effective as warfarin for long-term, extended antithrombotic therapy in patients who have already received at least three months of anticoagulation for VTE

Patients will consult with pharmacists, RNs, and PAs during health consultations offered right in their own neighborhoods

The popular guide by Harold Silverman, PhD, is now available as an app for iPhones, iPods, and iPads

Built-in timer notes when bottle was last opened

Shenandoah University, RxAlly, RealCME, and Kerr Drug to collaborate under Pfizer grant

Associations issues results of Medication Management in Care Transitions project

Drug Topics readers weigh in (04-15-2013)

Topical products for pain relief

New Rx, generics, OTC, and devices

The increase in utilization of generic drugs is driving costs down, while the increase in specialty pharmacy utilization is driving costs up, according to the 2013 CVS Caremark annual Insights Report.

Will FDA classify hydrocodone as Schedule III, Schedule II, or somewhere in between?

Guideline-directed medical therapy for heart failure (HF) is highly cost-effective and able to produce significant health gains for individuals with mild to moderate disease, according a study published April 2 in the Journal of the American College of Cardiology.

First new NVP approval in 50 years brings back 30-year-old drug

The antiarrhythmia drug amiodarone appears to be linked to a higher risk of cancer in men, specifically those who receive higher cumulative defined daily doses within the first year of treatment, according to a retrospective study published online April 8 in Cancer.

Ruling clears obstacles judge said were politically influenced

Pharmacists and other healthcare providers are still confusing Prilosec (omeprazole) and Prozac (fluoxetine) prescriptions, according to a new report from the Institute for Safe Medication Practices (ISMP).